C & L Urology Services Limited 13882355 false 2024-04-01 2025-03-31 2025-03-31 The principal activity of the company is that of specialist medical activites. Digita Accounts Production Advanced 6.30.9574.0 true 13882355 2024-04-01 2025-03-31 13882355 2025-03-31 13882355 bus:Director1 1 2025-03-31 13882355 bus:OrdinaryShareClass1 2025-03-31 13882355 bus:OrdinaryShareClass2 2025-03-31 13882355 bus:OrdinaryShareClass3 2025-03-31 13882355 core:RetainedEarningsAccumulatedLosses 2025-03-31 13882355 core:ShareCapital 2025-03-31 13882355 core:CurrentFinancialInstruments 2025-03-31 13882355 core:CurrentFinancialInstruments core:WithinOneYear 2025-03-31 13882355 core:FurnitureFittingsToolsEquipment 2025-03-31 13882355 bus:SmallEntities 2024-04-01 2025-03-31 13882355 bus:AuditExemptWithAccountantsReport 2024-04-01 2025-03-31 13882355 bus:FilletedAccounts 2024-04-01 2025-03-31 13882355 bus:SmallCompaniesRegimeForAccounts 2024-04-01 2025-03-31 13882355 bus:RegisteredOffice 2024-04-01 2025-03-31 13882355 bus:Director1 2024-04-01 2025-03-31 13882355 bus:Director1 1 2024-04-01 2025-03-31 13882355 bus:Director2 2024-04-01 2025-03-31 13882355 bus:OrdinaryShareClass1 2024-04-01 2025-03-31 13882355 bus:OrdinaryShareClass2 2024-04-01 2025-03-31 13882355 bus:OrdinaryShareClass3 2024-04-01 2025-03-31 13882355 bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 13882355 bus:Agent1 2024-04-01 2025-03-31 13882355 core:FurnitureFittingsToolsEquipment 2024-04-01 2025-03-31 13882355 countries:EnglandWales 2024-04-01 2025-03-31 13882355 2024-03-31 13882355 bus:Director1 1 2024-03-31 13882355 core:FurnitureFittingsToolsEquipment 2024-03-31 13882355 2023-04-01 2024-03-31 13882355 2024-03-31 13882355 bus:Director1 1 2024-03-31 13882355 bus:OrdinaryShareClass1 2024-03-31 13882355 bus:OrdinaryShareClass2 2024-03-31 13882355 bus:OrdinaryShareClass3 2024-03-31 13882355 core:RetainedEarningsAccumulatedLosses 2024-03-31 13882355 core:ShareCapital 2024-03-31 13882355 core:CurrentFinancialInstruments 2024-03-31 13882355 core:CurrentFinancialInstruments core:WithinOneYear 2024-03-31 13882355 core:FurnitureFittingsToolsEquipment 2024-03-31 13882355 bus:Director1 1 2023-04-01 2024-03-31 13882355 bus:Director1 1 2023-03-31 iso4217:GBP xbrli:pure xbrli:shares

Registration number: 13882355

C & L Urology Services Limited
Unaudited Filleted Financial Statements
for the Year Ended 31 March 2025

C & L Urology Services Limited

Contents

Company Information | 1
Accountants' Report | 2
Balance Sheet | 3
Notes to the Unaudited Financial Statements | 4 to 8

C & L Urology Services Limited

Company Information

Directors | Mr W G Britnell Mrs F D Britnell

Registered office | Wellesley House 204 London Road Waterlooville Hampshire PO7 7AN

Accountants | MMO Limited Wellesley House 204 London Road Waterlooville Hampshire PO7 7AN

Chartered Accountants' Report to the Board of Directors on the Preparation of the Unaudited Statutory Accounts of
C & L Urology Services Limited
for the Year Ended 31 March 2025

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the accounts of C & L Urology Services Limited for the year ended 31 March 2025 as set out on pages 3 to 8 from the company's accounting records and from information and explanations you have given us.

As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed at
http://www.icaew.com/regulation.

This report is made solely to the Board of Directors of C & L Urology Services Limited, as a body, in accordance with the terms of our engagement letter. Our work has been undertaken solely to prepare for your approval the accounts of C & L Urology Services Limited and state those matters that we have agreed to state to the Board of Directors of C & L Urology Services Limited, as a body, in this report in accordance with ICAEW Technical Release 07/16 AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than C & L Urology Services Limited and its Board of Directors as a body for our work or for this report.

It is your duty to ensure that C & L Urology Services Limited has kept adequate accounting records and to prepare statutory accounts that give a true and fair view of the assets, liabilities, financial position and profit of C & L Urology Services Limited. You consider that C & L Urology Services Limited is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or a review of the accounts of C & L Urology Services Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory accounts.

......................................
MMO Limited
Wellesley House
204 London Road
Waterlooville
Hampshire
PO7 7AN

22 October 2025

C & L Urology Services Limited

(Registration number: 13882355)
Balance Sheet as at 31 March 2025

| Note | 2025 £ | 2024 £
Fixed assets |  |  |
Tangible assets | 4 | 13,293 | 9,979
Current assets |  |  |
Debtors | 5 | 15,219 | 13,003
Cash at bank and in hand |  | 79,210 | 36,663
|  | 94,429 | 49,666
Creditors: Amounts falling due within one year | 6 | (11,194) | (6,305)
Net current assets |  | 83,235 | 43,361
Total assets less current liabilities |  | 96,528 | 53,340
Provisions for liabilities |  | (3,323) | (1,896)
Net assets |  | 93,205 | 51,444
Capital and reserves |  |  |
Called up share capital | 7 | 120 | 120
Retained earnings |  | 93,085 | 51,324
Shareholders' funds |  | 93,205 | 51,444

For the financial year ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

• | The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and
• | The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the Board on 21 October 2025 and signed on its behalf by:

......................................... Mr W G Britnell Director

C & L Urology Services Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025

1 | General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
Wellesley House
204 London Road
Waterlooville
Hampshire
PO7 7AN
England

2 | Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

All figures are presented in British Sterling, which is the functional currency of the company, and are rounded to the nearest £1.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.
The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Tax

The tax expense for the period comprises current and deferred tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

C & L Urology Services Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Deferred tax is recognised in respect of all timing differences between taxable profits and profits reported in the financial statements.
Unrelieved tax losses and other deferred tax assets are recognised when it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.
Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference.

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.
The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.
Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.
Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

C & L Urology Services Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Dividends

Dividend distribution to the company’s shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.

3 | Staff numbers

The average number of persons employed by the company (including directors) during the year, was 2 (2024 - 2).

4 | Tangible assets

| Furniture, fittings and equipment £ | Total £
Cost or valuation
At 1 April 2024 | 13,305 | 13,305
Additions | 7,746 | 7,746
At 31 March 2025 | 21,051 | 21,051
Depreciation
At 1 April 2024 | 3,326 | 3,326
Charge for the year | 4,432 | 4,432
At 31 March 2025 | 7,758 | 7,758
Carrying amount
At 31 March 2025 | 13,293 | 13,293
At 31 March 2024 | 9,979 | 9,979

C & L Urology Services Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025

5 | Debtors

Current | 2025 £ | 2024 £
Trade debtors | 10,963 | 13,003
Other debtors | 4,256 | -
| 15,219 | 13,003

6 | Creditors

Creditors: amounts falling due within one year

| 2025 £ | 2024 £
Due within one year |  |
Taxation and social security | 9,634 | 4,223
Accruals and deferred income | 1,560 | 1,560
Other creditors | - | 522
| 11,194 | 6,305

7 | Share capital

Allotted, called up and fully paid shares

| 2025 | 2024
| No. | £ | No. | £
Ordinary shares of £1 each | 100 | 100 | 100 | 100
Ordinary A shares of £1 each | 10 | 10 | 10 | 10
Ordinary B shares of £1 each | 10 | 10 | 10 | 10
| 120 | 120 | 120 | 120

C & L Urology Services Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025

8 | Related party transactions

Transactions with directors

2025 | At 1 April 2024 £ | Other payments made to company by director £ | At 31 March 2025 £
Mr W G Britnell
The directors loan account is undated, unsecured, interest free and repayable on demand. | (521) | 4,776 | 4,255

2024 | At 1 April 2023 £ | Other payments made to company by director £ | At 31 March 2024 £
Mr W G Britnell
The directors loan account is undated, unsecured, interest free and repayable on demand. | (25,250) | 24,729 | (521)